<TS-1> paints components, coating processes, curable composition, curable organopolysiloxane composition, organopolysiloxane and its functional group, hydrophilic silica, hydrophobic silica, thermal treatment of curable composition, thermal treatment of organopolysiloxane, organopolysiloxane, reactive termini, reactive terminals, thermal curing, curing condition, silicon-bonded alkenyl group, silicon-bonded aryl group, siloxane unit, silicon-bonded hydrogen atom, hydrosilylation catalyst, Shelf stability around room temperature, Moderate ultraviolet irradiation, Heating, condensation reaction, hydrophobic, hydrophilic, paints, coatings, polymerized siloxanes, polysiloxanes binders, silicones, surfactants, polymerization of the binder, silicon dioxide, Thermal degradation of polysiloxanes, synthesis of polysiloxanes, UV curing, polymeric organosilicon, polysiloxane, polymerized siloxanes, silicon resins, curable resins, Alkenylated organopolysiloxane, Organohydrogenpolysiloxane, Platinum catalyst, Thiophene compound, Isocyanide compound, Cyclic thioether compound, Cyclic azo ether compound, Imino compound, thermal characters, organic synthesis, organosilane, hydrophobic group, hydrophilic group
<TS-2> Dipetidyl peptidase-IV inhibitors, type-2 diabetes, Dipetidyl peptidase-IV inhibitors drugs, Dipetidyl peptidase-IV inhibitors compounds, dipetidyl peptidase-IV inhibitors, DPP-4 inhibitors, suppliers, companies, commercially avaliable, vildagliptin, drug interactions, glycemic control, glucagonlike peptide-1, amyylin analogue pramlintide, cannabinoid receptor-1, antihyperglycemic, DPP-4, enzyme-inhibitor, saxagliptin, linagliptin, Dipetidyl peptidase-IV inhibitor(s), therapeutic, sitagliptin, alogliptin, oral anti-diabetic therapy, inactivation of incretins, enzyme inhibitors, oral hypoglycemic agents, oral antihyperglycemic agents, anti-diabetic drugs, insulin, blood glucose, vildagliptin, sitaglitin, blood-glucose control, beta-hydroxysteroid dehydrogenase type 1, phmacokinetics, MK-0431, (2R)-4-oxo-4-[3-(trifluoromethyl)-5, 6-dihydro [1, 2, 4] triazolo [4, 3-a] pyrazin-7(8H)-yl]-1-(2, 4, 5-trifluorophenyl)butan-2-amine, Dipetidyl peptidase-4 inhibitors, FDA, oral, disease, DPP-IV, enzyme inhibitor
<TS-3> polyhydroxyalkanoate, PHA, 3-hydroxy-ω-substituted alkanoic acid, 3-hydroxy-ω-cyclohexylalkanoic acid, ω-cyclohexylalkanoic acid, ω-phenylalkanoic acid, ω-thienylalkanoic acid, microorganism, linear polyester, phenyl, thienyl, cyclohexyl, cyanocyclohexyl, nitrocyclohexyl, halocyclohexyl, methylcyclohexyl, ethylcyclohexyl
<TS-4>Hydroxylammonium salts, Substituted hydroxylamines (developmental), Customized grades, Oximating agents, Reducing agents, oxidizing agents, Customized molecules, HADS, hydroxylamine, di(2-sulphoethyl)hydroxylamine, color development, Silver Halide, AgX, N-methylhydroxylamine, hydrochloride, N-hydroxy-B-alanine, propionaldoxime, propionaldehyde, hydroxylamine, 1-nitropropane, CH3NHOH, NH2OH, silver salts, coordinate reaction
<TS-5> (E)-guggulsterone, (Z)-Guggulsterone, (17Z)-Pregna-4, 17(20)-diene-3, 16-dione, 	(17E)-isomer, pregna-4, 17-diene-3, (17Z)-isomer, (17E)-pregna-4, 17(20)-diene-3, Guggulsterone, Pregna-4, 17-diene-3, 16-dione synthesis, Guggulsterone synthesis, Pregna-4, 17-diene-3, 16-dione extraction, Guggulsterone extraction, Guggulsterone preparation, gugulipid, cis and trans-4, 17(20)-pregnadiene-3, E- and Z-guggulsterones, guggulipid preparations, reversed-phase column extraction
<TS-6> delta-9-tetrahydrocannabinol (Δ9-THC), Δ8-THC, Δ1-THC, dronabinol, tetrahydrocannabinol, purification of tetrahydrocannabinol, active ingredient of cannibis, purification of the active ingredient of cannibis, extraction of tetrahydrocannabinol, tetrahydrocannabinol, purification, cannabinoid, chromatography, separatio, tetrahydrocannabinol, cannibis, Cannabis, main isomer in Cannabis, THC derivatives, crystallised derivatives, delta-9-tetrahydrocannabinol, dronabinol, THC Gas chromatography, GC-Ms, solid phase extraction of benzodiazepines, liquid chromatography, gel chromatography, gas chromatography, marihuana, constituents, cannabis-satival HPLC, NMR, terpenoids, silica gel column
<TS-7> Minitab, statistical package, formulation, antithrombotics, F10, Stuart-Powder Factor, rivaroxaban, apixaban, otamixaban, thromobokinase, coagulation cascade, statistical analysis, FX, FXA, oral, disease
<TS-8> 1-diethyl-3-((6aR, 9S)-7-methyl- -4, 6, 6a, 7, 8, 9-hexahydroindolo[4, 3-fg]quinolin-9-yl)urea, Arolac, Cuvalit, Dipergon, Dopergin(e), Lysenyl Forte, Prolacam, Revanil, lisuride, Parkinsons-disease, transdermal delivery, Restless Leg Syndrome, lisuride subcutaneous, lisuride formulation, Dopergin®, RSL, Wittmaack-Ekbom's syndrome, Parkinson’s disease, dopamine, transdermal patch, subcutaneous injection, formulation, Transdermal delivery, Antilactation agent, Serotonin antagonist, neurological disorders, alzheimers-disease, neuropathic pain scale, dopamine agonist, therapy, FDA, 1, 1-diethyl-3-((6aR, 9S)-7-methyl-4, 6, 6a, 7, 8, 9 hexahydroindolo, [4, 3-fg] quinolin-9-yl) urea, Parkinson disease
<TS-9> hyperbranched, polyesteramides, ink-jet printings, ink solutions, patent
<TS-10> catalytic hydrotreating, catalytic hydrodewaxing, hydrocarbon feed stock, waxy paraffins, group VIB metal catalysts, porous oxide support, refractory oxide, silica molecular sieve, hydrotreating, hydrodewaxing, hydrocarbon, Group VIB metal, silica molecular sieve, catalyst, simultaneous hydrotreating, simultaneous hydrodewaxing, group 6 catalysts, chromium catalysts, molybdenum catalysts, tungsten catalysts, simultaneous catalyze, catalyze conditions
<TS-11> Heating-sensitive copying-paper, Antistatic film compositions and elements, Photothermographic silver halide element, Poly(2-propenenitrile co-1, 1 -dichloroethene-co-2-propenoic acid), Poly(2-propenoic acid, methyl-ester-co-1, 1dichloroethene-co-itaconic acid), Poly(vinyl alcohol), Poly(vinyl butyral) binder, alkylacrylates, methacrylates, acrylic acid, sulfoacrylates, methyl, ethyl, propyl, butyl, hexyl, acrylamide polymers, water-soluble cellulose derivatives, hydroxyl ethyl cellulose, water-soluble cellulose acetate, poly(vinyl alcohol), partially hydrolyzed
<TS-12> diazepam, muscle relaxant, diazepam and its treatment, diazepam, Valium, diazenius, benzodiazepine derivative drug, Valium, Roche, skeletal muscle relaxant, benzodiazepine, database, treatment, 7-chloro-1-methyl-5-phenyl-3H-1, 4-benzodiazepin-2-one, antispasticity agents, muscle hypertonicity, Ansiolisina, relanium, stesolid, apaurin, faustan, sibazon, seduxen, antispasmodics, 7-chloro-1, 3-dihydro-1-methyl-5-phenyl-2H-1, psychoactive drug, oral, IM, IV, muscle activity
<TS-13> patent, USPTO, CIPO, THC, dronabinol, Cannabis plant, cannabinoid receptors, anti-tumor, (−)-(6aR, 10aR)-6, 6, 9-trimethyl-3-pentyl-6a, 7, 8, 10a-tetrahydro-6H-benzo[c]chromen-1-ol, INN, immune system
<TS-14> magnesium stearate (MgSt), Foradile, Oxis, Atock, Atimos Modulite, Perforomist, formoterol or eformoterol, lactose monohydrate, trehalose
<TS-15> betaine anhydrous, methyl donor agent, homocysteine (Hcy), homocystinuria, atherosclerosis, blood clot, S-adenosylmethionine (SAMe), folic acid, vitamin B6, vitamin B12, Remethylation disorders, coronary artery disease, methionine
<TS-16> Diels-Alder reaction, Diels-Alder cycloaddition, gram scale, large-scale, synthesis, catalytic reactions, green chemistry, green catalysts, lower cost, cycloaddition, multi-gram scale, catalyst, DA reaction, light induce, heat induce, electronic effect, steric effect
<TS-17> emulsions, water in oil in oil, water-in-oil-in-oil, W/O/O
<TS-18> emulsions, water in oil, water-in-oil, W/O
